Exact Mass: 497.0410134
Exact Mass Matches: 497.0410134
Found 36 metabolites which its exact mass value is equals to given mass value 497.0410134,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
PharmaGSID_48519
C22H20BrN5O4 (497.06985800000007)
CONFIDENCE standard compound; INTERNAL_ID 605; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8485; ORIGINAL_PRECURSOR_SCAN_NO 8483 CONFIDENCE standard compound; INTERNAL_ID 605; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8517; ORIGINAL_PRECURSOR_SCAN_NO 8514 CONFIDENCE standard compound; INTERNAL_ID 605; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8527; ORIGINAL_PRECURSOR_SCAN_NO 8524 CONFIDENCE standard compound; INTERNAL_ID 605; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8557; ORIGINAL_PRECURSOR_SCAN_NO 8553 CONFIDENCE standard compound; INTERNAL_ID 605; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8573; ORIGINAL_PRECURSOR_SCAN_NO 8570 CONFIDENCE standard compound; INTERNAL_ID 605; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8576; ORIGINAL_PRECURSOR_SCAN_NO 8573
4-Methylumbelliferyl2-acetamido-2-deoxy-b-D-galactopyranoside6sulphatepotassiumsalt
C18H20KNO11S (497.0394110000001)
calcium trisodium pentetate
C14H18CaN3Na3O10 (497.03111580000007)
D064449 - Sequestering Agents > D002614 - Chelating Agents > D007502 - Iron Chelating Agents D020011 - Protective Agents > D000931 - Antidotes
4-Methylumbelliferyl 6-Sulfo-2-acetamido-2-deoxy-b-D-glucopyranoside, Potassium Salt
C18H20KNO11S (497.0394110000001)
ethyl 5-acetoxy-6-broMo-2-((1,3-dioxo-2,3-dihydro-1H-inden-2-yl)Methyl)-1-Methyl-1H-indole-3-carboxylate
C24H20BrNO6 (497.04739200000006)
(S)-2-(3-(Benzo[c][1,2,5]thiadiazole-4-sulfonamido)thiophene-2-carboxamido)-5-guanidinopentanoic Acid
2-deoxy-4-O-(4-deoxy-2-O-sulfo-alpha-L-threo-hex-4-enopyranuronosyl)-2-(sulfoamino)-alpha-D-glucopyranose
C12H19NO16S2 (497.01452539999997)
5-Methylcytidine 5 inverted exclamation marka-triphosphate
[[3-(2-Amino-4-hydroxy-1,4,7,8-tetrahydropteridin-6-yl)-2,3-dihydroxypropoxy]-hydroxyphosphoryl] phosphono hydrogen phosphate
[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl [(2,3-dihydroxybenzoyl)amino] phosphate
C17H18N6O10P- (497.08219980000007)
2-(Sulfoamino)-4-O-[(2R)-3alpha,4beta-dihydroxy-6-carboxy-3,4-dihydro-2H-pyran-2beta-yl]-6-O-sulfo-2-deoxy-alpha-D-glucopyranose
C12H19NO16S2 (497.01452539999997)
2-Chloro-5-[[5-[[5-(4,5-Dimethyl-2-nitrophenyl)-2-furanyl]methylene]-4,5-dihydro-4-oxo-2-thiazolyl]amino]benzoic acid
C23H16ClN3O6S (497.04483060000007)
2-[(5-chloro-1,3-benzothiazol-2-yl)thio]-N-[3-(4-morpholinylsulfonyl)phenyl]propanamide
C20H20ClN3O4S3 (497.0304430000001)
2-deoxy-5-hydroxymethyl-CTP
A pyrimidine 2-deoxyribonucleoside 5-triphosphate that is 2deoxycytidine-5-triphosphate substituted by a hydroxymethyl group at position 5.
FAAH inhibitor 1
FAAH inhibitor 1 (Benzothiazole analog 3) is a potent fatty acid amide hydrolase (FAAH) inhibitor with an IC50 of 18±8 nM[1].
Lu AF27139
C21H19ClF3N5O2S (497.0900020000001)
Lu AF27139 is a potent, selective, and orally active antagonist of P2X7 receptor (IC50s of 12 and 2.4 nM for human and rat, Kis of 22, 54, and 13 nM for mouse, human, and rat, respectively). Lu AF27139 has rodent-active and CNS-penetrant character. Lu AF27139 has the potential for the research of CNS diseases[1].
15'-(aminomethyl)-7'-bromo-16'-chloro-5-hydroxy-2,3'-diimino-2',4',9',12'-tetraazaspiro[imidazolidine-4,17'-pentacyclo[10.6.0.0¹,⁵.0⁶,¹⁰.0¹⁴,¹⁸]octadecane]-6'(10'),7'-dien-11'-one
C17H21BrClN9O2 (497.06900160000004)
[(e)-[(4r)-4-hydroxy-7-methanesulfonyl-1-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}heptylidene]amino]oxysulfonic acid
(1'r,4r,5r,5's,14'r,15's,16'r,18's)-15'-(aminomethyl)-8'-bromo-16'-chloro-5-hydroxy-2,3'-diimino-2',4',6',12'-tetraazaspiro[imidazolidine-4,17'-pentacyclo[10.6.0.0¹,⁵.0⁶,¹⁰.0¹⁴,¹⁸]octadecane]-7',9'-dien-11'-one
C17H21BrClN9O2 (497.06900160000004)
(1s)-4'-amino-4-[(4-amino-5-carboxy-3,6-dioxocyclohexa-1,4-dien-1-yl)amino]-7-hydroxy-3'-methoxy-3,6'-dioxospiro[2-benzofuran-1,1'-cyclohexane]-2',4'-diene-5'-carboxylic acid
4-[(5-carboxy-6-hydroxy-4-imino-3-oxocyclohexa-1,5-dien-1-yl)amino]-6',7-dihydroxy-4'-imino-3'-methoxy-3-oxospiro[2-benzofuran-1,1'-cyclohexane]-2',5'-diene-5'-carboxylic acid
4'-amino-4-[(4-amino-5-carboxy-3,6-dioxocyclohexa-1,4-dien-1-yl)amino]-7-hydroxy-3'-methoxy-3,6'-dioxospiro[2-benzofuran-1,1'-cyclohexane]-2',4'-diene-5'-carboxylic acid
(1'r,4r,5s,5's,14's,15's,16's,18's)-15'-(aminomethyl)-7'-bromo-16'-chloro-5-hydroxy-2,3'-diimino-2',4',9',12'-tetraazaspiro[imidazolidine-4,17'-pentacyclo[10.6.0.0¹,⁵.0⁶,¹⁰.0¹⁴,¹⁸]octadecane]-6'(10'),7'-dien-11'-one
C17H21BrClN9O2 (497.06900160000004)
(1's,4s,5r,5'r,14's,15'r,16's,18'r)-15'-(aminomethyl)-7'-bromo-16'-chloro-5-hydroxy-2,3'-diimino-2',4',9',12'-tetraazaspiro[imidazolidine-4,17'-pentacyclo[10.6.0.0¹,⁵.0⁶,¹⁰.0¹⁴,¹⁸]octadecane]-6'(10'),7'-dien-11'-one
C17H21BrClN9O2 (497.06900160000004)
15'-(aminomethyl)-8'-bromo-16'-chloro-5-hydroxy-2,3'-diimino-2',4',6',12'-tetraazaspiro[imidazolidine-4,17'-pentacyclo[10.6.0.0¹,⁵.0⁶,¹⁰.0¹⁴,¹⁸]octadecane]-7',9'-dien-11'-one
C17H21BrClN9O2 (497.06900160000004)
(1'r,4r,5r,5's,14'r,15's,16'r,18's)-15'-(aminomethyl)-7'-bromo-16'-chloro-5-hydroxy-2,3'-diimino-2',4',9',12'-tetraazaspiro[imidazolidine-4,17'-pentacyclo[10.6.0.0¹,⁵.0⁶,¹⁰.0¹⁴,¹⁸]octadecane]-6'(10'),7'-dien-11'-one
C17H21BrClN9O2 (497.06900160000004)